NO20091694L - Anvendelse av modifiserte cyklosporiner - Google Patents

Anvendelse av modifiserte cyklosporiner

Info

Publication number: NO20091694L
Authority: NO; Norway
Prior art keywords: cyclosporins; modified; modified cyclosporins; contraception; treatment
Prior art date: 2006-10-12

Application number

NO20091694A

Other languages

English (en)

Norwegian (no)

Inventor

Motoyuki Kohjima

Makoto Nakamuta

Original Assignee

Univ Kyushu

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-12

Filing date

2009-04-28

Publication date

2009-07-10

2009-04-28 Application filed by Univ Kyushu filed Critical Univ Kyushu

2009-07-10 Publication of NO20091694L publication Critical patent/NO20091694L/no

Links

229930182912 cyclosporin Natural products 0.000 title abstract 2
108010036941 Cyclosporins Proteins 0.000 title 1
102000001493 Cyclophilins Human genes 0.000 abstract 1
108010068682 Cyclophilins Proteins 0.000 abstract 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
229930105110 Cyclosporin A Natural products 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
208000019423 liver disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20091694A 2006-10-12 2009-04-28 Anvendelse av modifiserte cyklosporiner NO20091694L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US82922806P	2006-10-12	2006-10-12
PCT/EP2007/060794 WO2008043797A1 (fr)	2006-10-12	2007-10-10	Utilisation de cyclosporines modifiées

Publications (1)

Publication Number	Publication Date
NO20091694L true NO20091694L (no)	2009-07-10

Family

ID=39092021

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091694A NO20091694L (no)	2006-10-12	2009-04-28	Anvendelse av modifiserte cyklosporiner

Country Status (17)

Country	Link
US (1)	US20100130408A1 (fr)
EP (1)	EP2073831A1 (fr)
JP (1)	JP5455632B2 (fr)
KR (1)	KR20090083902A (fr)
CN (1)	CN101557819A (fr)
AU (1)	AU2007306316B2 (fr)
BR (1)	BRPI0719189A2 (fr)
CA (1)	CA2665415A1 (fr)
IL (1)	IL197966A0 (fr)
MA (1)	MA30865B1 (fr)
MX (1)	MX2009003743A (fr)
NO (1)	NO20091694L (fr)
RU (1)	RU2463071C2 (fr)
SG (1)	SG175621A1 (fr)
TN (1)	TN2009000135A1 (fr)
WO (1)	WO2008043797A1 (fr)
ZA (1)	ZA200902300B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011063076A1 (fr)	2009-11-19	2011-05-26	Itherx Pharmaceuticals, Inc.	Méthodes de traitement du virus de l'hépatite c avec des composés d'oxo-acétamide
CN101843893B (zh) *	2010-05-21	2012-02-01	中国人民解放军第三军医大学	环孢素a在制备抗轮状病毒药物中的应用
EP3351247A1 (fr) *	2010-06-01	2018-07-25	Auspex Pharmaceutical, Inc.	Inhibiteurs benzoquinolone de vmat2
US9550780B2 (en)	2012-09-18	2017-01-24	Auspex Pharmaceuticals, Inc.	Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
EP4345100A3 (fr)	2012-09-18	2024-04-10	Auspex Pharmaceuticals, Inc.	Formulations pharmacocinétiques d'inhibiteurs de benzoquinoline deutérés du transporteur vésiculaire de monoamine 2
WO2015084622A1 (fr)	2013-12-03	2015-06-11	Auspex Pharmaceuticals, Inc.	Procédés de production de composés de benzoquinoline
AU2016229949B2 (en)	2015-03-06	2021-04-08	Auspex Pharmaceuticals Llc	Methods for the treatment of abnormal involuntary movement disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5639724A (en) *	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
US5908621A (en) *	1995-11-02	1999-06-01	Schering Corporation	Polyethylene glycol modified interferon therapy
FR2757521B1 (fr) *	1996-12-24	1999-01-29	Rhone Poulenc Rorer Sa	Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757522B1 (fr) *	1996-12-24	1999-01-29	Rhone Poulenc Rorer Sa	Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH1180026A (ja) *	1997-09-02	1999-03-23	Yoshitomi Pharmaceut Ind Ltd	新規免疫抑制剤、その使用方法およびその同定方法
US20030216303A1 (en) *	1998-03-06	2003-11-20	Michael Ambuhl	Emulsion preconcentrates containing cyclosporin or a macrolide
AU759480B2 (en) *	1998-07-01	2003-04-17	Debiopharm S.A.	Novel cyclosporin with improved activity profile
EP1177796B1 (fr) *	1999-04-27	2011-04-27	Mitsubishi Tanabe Pharma Corporation	Médicament pour la prévention ou le traitement des maladies du foie
AU2001292301A1 (en) *	2000-10-11	2002-04-22	Daiichi Pharmaceutical Co., Ltd.	Novel drugs for liver diseases
US20030213603A1 (en) *	2002-05-14	2003-11-20	Fisher David B.	Dual use extension apparatus for a tool
GB0320638D0 (en) *	2003-09-03	2003-10-01	Novartis Ag	Organic compounds
US7079552B2 (en) *	2003-09-09	2006-07-18	Harris Corporation	Mobile ad hoc network (MANET) with quality-of-service (QoS) protocol hierarchy and related methods
DK1793844T3 (da) *	2004-10-01	2011-03-21	Debiopharm Sa	Anvendelse af [D-MeAla]3-[EtVal]4-cyklosporin til behandling af hepatitis C-infektion
SI1802650T1 (sl) *	2004-10-01	2012-03-30	Scynexis Inc	Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c
WO2006071619A1 (fr) *	2004-12-23	2006-07-06	Novartis Ag	Compositions pour le traitement du vhc
US8512690B2 (en) *	2009-04-10	2013-08-20	Novartis Ag	Derivatised proline containing peptide compounds as protease inhibitors

2007
- 2007-10-10 CA CA002665415A patent/CA2665415A1/fr not_active Abandoned
- 2007-10-10 RU RU2009117699/15A patent/RU2463071C2/ru not_active IP Right Cessation
- 2007-10-10 MX MX2009003743A patent/MX2009003743A/es active IP Right Grant
- 2007-10-10 CN CNA2007800410447A patent/CN101557819A/zh active Pending
- 2007-10-10 BR BRPI0719189A patent/BRPI0719189A2/pt not_active IP Right Cessation
- 2007-10-10 US US12/444,941 patent/US20100130408A1/en not_active Abandoned
- 2007-10-10 SG SG2011074572A patent/SG175621A1/en unknown
- 2007-10-10 JP JP2009531841A patent/JP5455632B2/ja not_active Expired - Fee Related
- 2007-10-10 AU AU2007306316A patent/AU2007306316B2/en not_active Ceased
- 2007-10-10 KR KR1020097009615A patent/KR20090083902A/ko not_active Ceased
- 2007-10-10 EP EP07821161A patent/EP2073831A1/fr not_active Withdrawn
- 2007-10-10 WO PCT/EP2007/060794 patent/WO2008043797A1/fr not_active Ceased
2009
- 2009-04-02 ZA ZA200902300A patent/ZA200902300B/xx unknown
- 2009-04-05 IL IL197966A patent/IL197966A0/en unknown
- 2009-04-10 TN TNP2009000135A patent/TN2009000135A1/fr unknown
- 2009-04-28 NO NO20091694A patent/NO20091694L/no not_active Application Discontinuation
- 2009-05-06 MA MA31842A patent/MA30865B1/fr unknown

Also Published As

Publication number	Publication date
WO2008043797A1 (fr)	2008-04-17
KR20090083902A (ko)	2009-08-04
MX2009003743A (es)	2009-06-18
JP5455632B2 (ja)	2014-03-26
SG175621A1 (en)	2011-11-28
TN2009000135A1 (en)	2010-10-18
IL197966A0 (en)	2011-08-01
JP2010505912A (ja)	2010-02-25
ZA200902300B (en)	2010-10-27
AU2007306316B2 (en)	2011-10-27
MA30865B1 (fr)	2009-11-02
RU2463071C2 (ru)	2012-10-10
US20100130408A1 (en)	2010-05-27
CN101557819A (zh)	2009-10-14
BRPI0719189A2 (pt)	2018-08-14
EP2073831A1 (fr)	2009-07-01
AU2007306316A1 (en)	2008-04-17
RU2009117699A (ru)	2010-11-20
CA2665415A1 (fr)	2008-04-17

Similar Documents

Publication	Publication Date	Title
NO20091694L (no)	2009-07-10	Anvendelse av modifiserte cyklosporiner
TNSN06071A1 (en)	2007-10-03	Use of modified cyclosporins for the treatment of hcv disorders
TNSN07240A1 (en)	2008-11-21	Compounds for flaviviridae treatment
CL2009000200A1 (es)	2010-09-10	Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune.
CL2007000789A1 (es)	2008-01-18	Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
CL2007000161A1 (es)	2008-05-30	Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
WO2008003007A3 (fr)	2008-05-22	Compositions et procédés destinés au traitement d'infections parasitaires
HUS1700012I1 (hu)	2017-05-29	Bruton-tirozinkináz inhibitorok
CL2007002261A1 (es)	2008-05-02	Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
CL2008001855A1 (es)	2009-05-29	Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
CL2008001122A1 (es)	2008-10-24	Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
UA98658C2 (uk)	2012-06-11	Циклічні депсипептиди
CL2007001993A1 (es)	2008-06-20	Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
MX2009003129A (es)	2009-04-06	Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.
CL2007002619A1 (es)	2008-04-18	Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
AU308855S (en)	2006-08-16	Camera
IL192373A (en)	2015-09-24	Arginine cyclic peptides and their use in the treatment of fungal infections
MY162640A (en)	2017-06-30	Thioninium compounds and their use
CL2007003038A1 (es)	2008-06-06	Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
PE20080338A1 (es)	2008-04-25	4-[5-(2-amino-etansulfonil)-isoquinolin-7-il]-fenol como inhibidor de akt (proteina cinasa)
CL2008002353A1 (es)	2008-10-24	Compuestos derivados de 7h-indolo[2,1-a][2]benzazepina; composicion farmaceutica; y uso en el tratamiento de la hepatitis c.
BRPI0811538A2 (pt)	2015-08-11	Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.
CL2012001757A1 (es)	2013-03-22	Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.
CL2007002769A1 (es)	2008-07-04	Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
CL2008003602A1 (es)	2009-10-09	Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.

Legal Events

Date	Code	Title	Description
2015-05-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application